{"podcast":{"title":"Hims House","slug":"hims-house-7026583","podcast_index_feed_id":7026583,"rss_url":"https://anchor.fm/s/10e9c0874/podcast/rss","website_url":"https://himshouse.substack.com/podcast","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/45300741/1466fea8bed61dc7.jpg","author":"Jonathan Stern","episode_count":73,"summary":"Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. himshouse.substack.com","last_synced_at":"2026-07-08T00:20:15.279819+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583"},"episode":{"title":"Saad Alam (CEO, Hone Health) - Longevity, testosterone, & peptides","slug":"saad-alam-ceo-hone-health-longevity-testosterone-peptides","published_at":"2025-10-14T15:13:45+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/saad-alam-ceo-hone-health-longevity-testosterone-peptides","show_page_url":"https://stenobird.com/podcast/hims-house-7026583","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Saad-Alam-CEO--Hone-Health---Longevity--testosterone---peptides-e3egqlp","audio_url":"https://anchor.fm/s/10e9c0874/podcast/play/114894969/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-2%2F417288026-44100-2-4b61b61baa1923c5.mp3","summary":"In episode 48 of Hims House, Jonathan Stern and Patrick Lester (Bayside) are joined by Saad Alam, founder & CEO of Hone Health. The discussion dives into Saad’s personal health journey and the founding of Hone Health during the pandemic. Saad discusses the company’s focus on hormonal health, weight loss, thyroid medications, and new longevity medications. Saad shares insights into diagnostics, the future of primary care, implications of the Meta ad privacy policy changes and FDA advertising crackdown, and the future of the telehealth industry. 00:43 Saad’s personal health journey 02:34 Hone’s products, revenue, competitors 04:29 Enclomiphene vs. clomiphene 09:07 Testosterone market and demographics 14:10 What longevity means 19:25 Lab testing and biomarkers 22:09 Why Hone hasn’t offered GLP-1s 25:14 “Everyone has a Chinese peptide dealer now” 33:53 Which peptides should Hims start with 35:38 Meta ads and the FDA crackdown on ads 40:43 Is primary care in trouble? 47:52 Why Saad is bullish on Hims Get full access to Hims House at himshouse.substack.com/subscribe","meta_description":"In episode 48 of Hims House, Jonathan Stern and Patrick Lester (Bayside) are joined by Saad Alam, founder & CEO of Hone Health. The discussion dives i…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3085,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/saad-alam-ceo-hone-health-longevity-testosterone-peptides/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/saad-alam-ceo-hone-health-longevity-testosterone-peptides.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}